Artwork

محتوای ارائه شده توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Dr. Joel Palefsky: The Father of Anal Dysplasia Screening, Treatment, and Research

35:39
 
اشتراک گذاری
 

Manage episode 407390346 series 3561422
محتوای ارائه شده توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 407390346 series 3561422
محتوای ارائه شده توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 قسمت

همه قسمت ها

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع